Compare BNTX & HAL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | BNTX | HAL |
|---|---|---|
| Founded | 2008 | 1919 |
| Country | Germany | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Oilfield Services/Equipment |
| Sector | Health Care | Energy |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 24.8B | 24.4B |
| IPO Year | 2019 | N/A |
| Metric | BNTX | HAL |
|---|---|---|
| Price | $92.04 | $27.53 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 11 | 16 |
| Target Price | ★ $137.40 | $32.06 |
| AVG Volume (30 Days) | 1.4M | ★ 10.7M |
| Earning Date | 11-03-2025 | 01-21-2026 |
| Dividend Yield | N/A | ★ 2.45% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 1.52 |
| Revenue | $3,698,814,972.00 | ★ $22,137,000,000.00 |
| Revenue This Year | $2.36 | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $18.30 |
| Revenue Growth | ★ 3.70 | N/A |
| 52 Week Low | $81.20 | $18.72 |
| 52 Week High | $129.27 | $30.40 |
| Indicator | BNTX | HAL |
|---|---|---|
| Relative Strength Index (RSI) | 33.64 | 51.73 |
| Support Level | $91.26 | $26.79 |
| Resistance Level | $93.76 | $29.67 |
| Average True Range (ATR) | 2.27 | 0.82 |
| MACD | -0.39 | -0.09 |
| Stochastic Oscillator | 6.97 | 40.83 |
BioNTech is a Germany-based biotechnology company that focuses on developing cancer therapeutics, including individualized immunotherapy, as well as vaccines for infectious diseases, including covid. The company's oncology pipeline contains several classes of drugs, including mRNA-based drugs to encode antigens, neoantigens, cytokines, and antibodies; cell therapies; bispecific antibodies; and antibody-drug conjugates, or ADCs. Comirnaty, its Pfizer-partnered covid vaccine, is its first commercialized product.
Halliburton is North America's largest oilfield-services company as measured by market share. Despite industry fragmentation, it holds a leading position in the hydraulic fracturing and completions market, which makes up nearly half of its revenue. It also holds strong positions in other service offerings like drilling and completions fluids, which leverages its expertise in material science, as well as the directional drilling market. While we consider SLB the global leader in reservoir evaluation, we think Halliburton leads in any activity from the reservoir to the wellbore. Halliburton's innovations have helped multiple producers lower their development costs per barrel of oil equivalent, with techniques that have been honed over a century of operations.